Azzad Asset Management Inc /Adv 10x Genomics, Inc. Transaction History

Azzad Asset Management Inc /Adv

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Apr 01, 2024	SELL	$135.05 - $182.59 $630,143 - $851,964	-4,666 Closed	0 $0
Q3 2021 Apr 01, 2024	BUY	$145.58 - $192.14 $3,202 - $4,227	22 Added 0.47%	4,666 $679 Million
Q2 2021 Apr 01, 2024	BUY	$134.22 - $202.37 $12,616 - $19,022	94 Added 2.07%	4,644 $909 Million
Q1 2021 Apr 01, 2024	BUY	$140.25 - $196.86 $82,607 - $115,950	589 Added 14.87%	4,550 $823 Million
Q4 2020 Apr 01, 2024	BUY	$126.47 - $163.7 $500,947 - $648,415	3,961 New	3,961 $561 Million

287

94.9M

162K

107K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.54B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.